Nir Barzilai MD Overview
Nir Barzilai MD General Information
Biography
Dr. Nir Barzilai serves as a Venture Partner at quadraScope Venture Fund. He serves as Chief Medical Advisor and Board Member at SirTLab. He was a Co-Founder and served as a Board Member at CohBar. He co-founded the company in 2007 and has served as a member of the board of directors since the conversion to a Delaware corporation in 2009. He is the Director of the Institute for Aging Research at the Albert Einstein College of Medicine of Yeshiva University, where he also holds the Ingeborg and Ira Leon Rennert Chair of Aging Research, is a professor in the Departments of Medicine and Genetics and a member of the Diabetes Research Center. He is also Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health's (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He has received numerous awards, including the Beeson Fellow for Aging Research, the Ellison Medical Foundation Senior Scholar in Aging Award, the Paul F. Glenn Foundation Award, the NIA Nathan Shock Award, and the 2010 Irving S. Wright Award of Distinction in Aging Research. He also serves as an Advisory Board Member at LongeVC. Renowned for his significant contributions to advancing the understanding of aging and promoting research in the field, Prof. Nir Barzilai holds the positions of Director of the Institute for Aging Research at the Albert Einstein College of Medicine, Director of the Paul F. Glenn Center for the Biology of Human Aging Research, and Director of the National Institutes of Health's (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. Additionally, Prof. Barzilai serves as the Scientific Director of the American Federation for Aging Research (AFAR).
Contact Information
Address
- Via Calprino 18
- Paradiso
- 6909 Lugano
- Switzerland
Nir Barzilai MD Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
quadraScope Ventures | Investor | Venture Partner | Littleton, MA | Venture Capital |
Nir Barzilai MD Board Seats (2)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
LongeVC | Lugano, Switzerland | ||||
SirTLab | Drug Discovery | Privately Held (backing) | Angel-Backed | Ness Ziona, Israel |
Nir Barzilai MD Network (32)
Board Members (19)
Name | Company | Representing | Location | From |
---|---|---|---|---|
John Amatruda MD | CohBar | CohBar | Menlo Park, CA | |
Pinchas Cohen MD | CohBar | CohBar | Menlo Park, CA | |
CohBar | Self | Menlo Park, CA | ||
CohBar | Self | Menlo Park, CA | ||
SirTLab | SirTLab | Ness Ziona, Israel |
Fund Team Members (13)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Lan Clark | quadraScope Ventures | quadraScope Venture Fund I | Littleton, MA |
Frank Wellens | quadraScope Ventures | quadraScope Venture Fund I | Littleton, MA |
quadraScope Ventures | Littleton, MA | ||
quadraScope Ventures | Littleton, MA | ||
quadraScope Ventures | Littleton, MA |
Nir Barzilai MD Affiliated Funds (1)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
quadraScope Venture Fund I | quadraScope Ventures | Venture Capital - Early Stage | Open | 2023 |
Nir Barzilai MD FAQs
-
Who is Nir Barzilai MD?
Dr. Nir Barzilai serves as a Venture Partner at quadraScope Venture Fund.
-
How much does Nir Barzilai MD typically invest?
Nir Barzilai MD's median deal size is
. -
What is Nir Barzilai MD’s main position?
Nir Barzilai MD’s primary position is Founder & Board Member.
-
How many active board seats does Nir Barzilai MD hold?
Nir Barzilai MD holds 2 board seats including LongeVC and SirTLab.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »